ask="N/A"
ask_size="N/A"
average_daily_volume="11160"
bid="4.0000"
bid_size="500"
book_value="-2.0510"
change="+0.0031"
change_from_200_day_moving_average="-0.1156"
change_from_50_day_moving_average="-0.0484"
change_from_52_week_high="-1.2469"
change_From_52_week_low="0.4231"
change_in_percent="+0.0713%"
close="4.3531"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.8770"
ebitda="-3.99M"
eps_estimate_current_year="-2.9500"
eps_estimate_next_quarter="-0.1300"
eps_estimate_next_year="-0.4800"
ex_dividend_date="N/A"
float_shares="2882000"
high="4.3531"
high_52_weeks="5.6000"
last_trade_date="1/24/2017"
last_trade_price="4.3531"
last_trade_size="729"
last_trade_time="2:22pm"
low="4.3110"
low_52_weeks="3.9300"
market_capitalization="41.92M"
moving_average_200_day="4.4687"
moving_average_50_day="4.4015"
name="AzurRx BioPharma
Inc."
notes="N/A"
one_year_target_price="7.0000"
open="4.3110"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-2.5864%"
percent_change_from_50_day_moving_average="-1.0992%"
percent_change_from_52_week_high="-22.2661%"
percent_change_from_52_week_low="+10.7659%"
previous_close="4.3500"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="9631000"
short_ratio="0.5300"
stock_exchange="NCM"
symbol="AZRX"
volume="1232"
weeks_range_52="3.9300 - 5.6000"
